The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
Patalganga plant received zero observation from USFDA earlier
CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
SPARC enters definitive agreement to monetise rare paediatric disease PRV, unlocking capital for R&D and strategic growth
Subscribe To Our Newsletter & Stay Updated
